These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1781714)

  • 1. [Ciprofloxacin in the prevention and treatment of surgical infections].
    Iakovlev VP; Blatun LA; Khlebnikov EP; Makarenkova RV; Elagina LV; Puchkova LS; Kutsidi EV
    Antibiot Khimioter; 1991 Sep; 36(9):44-6. PubMed ID: 1781714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Hauptman JG; MacDonald KH; Budsberg SC; Rosser EJ
    Am J Vet Res; 1990 Jun; 51(6):896-900. PubMed ID: 2195927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ciprofloxacin in the treatment of infections in oncology patients].
    Dronova OM
    Antibiot Khimioter; 1990 Nov; 35(11):51-4. PubMed ID: 2092640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ciprofloxacine: evaluation of its biliary elimination in man].
    Brogard JM; Jehl F; Arnaud JP; Lévy P; Peladan F; Blicklé JF; Monteil H
    Schweiz Med Wochenschr; 1985 Mar; 115(13):448-53. PubMed ID: 3158073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary kinetics and excretion of ciprofloxacin.
    Parry MF; Smego DA; Digiovanni MA
    Antimicrob Agents Chemother; 1988 Jul; 32(7):982-5. PubMed ID: 3190199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of intravenous and oral ciprofloxacin into sterile and empyemic human pleural fluid.
    Joseph J; Vaughan LM; Basran GS
    Ann Pharmacother; 1994 Mar; 28(3):313-5. PubMed ID: 8193415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
    Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P
    Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Voiriot P; Dopff C; Scholl H; Clavey M; Villemot JP; Canton P; Dureux JB
    Antimicrob Agents Chemother; 1990 Mar; 34(3):398-401. PubMed ID: 2185690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin antibacterial activity and concentrations in serum and the surgical wound in dogs.
    Rosin E; Uphoff TS; Schultz-Darken NJ; Collins MT
    Am J Vet Res; 1993 Aug; 54(8):1317-21. PubMed ID: 8214903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial efficacy and pharmacokinetic studies of ciprofloxacin on Pasteurella multocida infected rabbits.
    Hanan MS; Riad EM; el-Khouly NA
    Dtsch Tierarztl Wochenschr; 2000 Apr; 107(4):151-5. PubMed ID: 10829566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical evaluation of latamoxef in pediatric surgery].
    Yura J; Hayashi S; Tsuruga N; Hashimoto T; Murata Y; Kamiya Y
    Jpn J Antibiot; 1983 Sep; 36(9):2383-90. PubMed ID: 6655856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ciprofloxacin concentration in human prostatic tissue following 3 days' administration].
    Morita M; Nakagawa H; Suzuki K
    Hinyokika Kiyo; 1991 May; 37(5):563-6. PubMed ID: 1713402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ciprofloxacin in the treatment of experimental intra-abdominal abscesses in mice.
    Esposito S
    Clin Ther; 1989; 11(1):32-7. PubMed ID: 2720726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of ciprofloxacin in human liver, gallbladder, and bile after oral administration.
    Dan M; Verbin N; Gorea A; Nagar H; Berger SA
    Eur J Clin Pharmacol; 1987; 32(2):217-8. PubMed ID: 3582488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin biliary disposition in cholecystectomised patients with special references to HPLC and bioassay data.
    Jehl F; Adloff M; Monteil H; Brogard JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):115-22. PubMed ID: 3691576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment of CAPD-peritonitis with ciprofloxacin.
    Boeschoten EW; Kuijper EJ; Speelman P; Struijk DG; Krediet RT; Arisz L
    Adv Perit Dial; 1990; 6():126-9. PubMed ID: 1982789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of ciprofloxacin into human peritoneal tissue following a single oral dose of 750 milligrams.
    Dan M; Serour F; Poch F
    J Chemother; 1992 Feb; 4(1):27-9. PubMed ID: 1403066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of ciprofloxacin in bone tissue].
    Meissner A; Borner K
    Aktuelle Traumatol; 1993 Apr; 23(2):80-4. PubMed ID: 8098576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of oral ciprofloxacin in a patient with cardiogenic shock.
    Ujhelyi MR; Sullivan M; Nightingale C
    Pharmacotherapy; 1991; 11(4):336-9. PubMed ID: 1923916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.